| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Nephropathies | 29 | 2019 | 988 | 1.830 |
Why?
|
| Diabetes Mellitus, Type 1 | 27 | 2024 | 3454 | 1.520 |
Why?
|
| Metformin | 5 | 2020 | 912 | 1.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 17 | 2020 | 12289 | 1.140 |
Why?
|
| C-Peptide | 2 | 2019 | 433 | 1.070 |
Why?
|
| Calcium Channel Blockers | 3 | 2018 | 694 | 1.040 |
Why?
|
| Hypoglycemic Agents | 9 | 2024 | 3149 | 1.000 |
Why?
|
| Cations, Divalent | 1 | 2024 | 168 | 0.940 |
Why?
|
| Insulin | 16 | 2017 | 6596 | 0.930 |
Why?
|
| Diabetes Mellitus | 9 | 2022 | 5890 | 0.920 |
Why?
|
| Renal Insufficiency, Chronic | 7 | 2020 | 2290 | 0.900 |
Why?
|
| Leishmaniasis | 17 | 1990 | 66 | 0.870 |
Why?
|
| Kidney Transplantation | 11 | 2021 | 4214 | 0.810 |
Why?
|
| Kidney Failure, Chronic | 15 | 2021 | 2470 | 0.800 |
Why?
|
| Organ Transplantation | 4 | 2020 | 1150 | 0.780 |
Why?
|
| Altitude | 1 | 2022 | 159 | 0.740 |
Why?
|
| Blood Glucose | 12 | 2020 | 6379 | 0.730 |
Why?
|
| Heart Transplantation | 3 | 2020 | 3224 | 0.720 |
Why?
|
| Heart Failure | 13 | 2022 | 11848 | 0.680 |
Why?
|
| Cardiovascular Diseases | 14 | 2020 | 15760 | 0.660 |
Why?
|
| Calcium Channels | 2 | 2023 | 619 | 0.640 |
Why?
|
| Insulin, Long-Acting | 1 | 2017 | 58 | 0.580 |
Why?
|
| Hypertension | 10 | 2018 | 8595 | 0.560 |
Why?
|
| Renal Dialysis | 13 | 2018 | 1801 | 0.550 |
Why?
|
| Angina Pectoris | 4 | 2019 | 969 | 0.530 |
Why?
|
| Host-Pathogen Interactions | 1 | 2024 | 1447 | 0.520 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2024 | 1903 | 0.510 |
Why?
|
| Dehydration | 1 | 2017 | 216 | 0.500 |
Why?
|
| Acidosis, Lactic | 1 | 2017 | 145 | 0.500 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2023 | 930 | 0.490 |
Why?
|
| Autonomic Nervous System | 5 | 2006 | 697 | 0.480 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 841 | 0.480 |
Why?
|
| Fibrinogen | 3 | 2013 | 887 | 0.480 |
Why?
|
| Fumarates | 2 | 2016 | 131 | 0.460 |
Why?
|
| Pharmacists | 1 | 2016 | 259 | 0.450 |
Why?
|
| Diabetic Angiopathies | 6 | 2019 | 822 | 0.440 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 857 | 0.430 |
Why?
|
| Hematinics | 3 | 2015 | 281 | 0.410 |
Why?
|
| Kidney | 5 | 2022 | 7064 | 0.410 |
Why?
|
| Hemofiltration | 1 | 2012 | 59 | 0.410 |
Why?
|
| Quinolines | 1 | 2018 | 759 | 0.410 |
Why?
|
| Kidney Diseases | 3 | 2019 | 2093 | 0.400 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 586 | 0.400 |
Why?
|
| Renal Insufficiency | 3 | 2016 | 820 | 0.400 |
Why?
|
| Amides | 2 | 2016 | 448 | 0.400 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2006 | 854 | 0.390 |
Why?
|
| Antihypertensive Agents | 3 | 2016 | 2061 | 0.380 |
Why?
|
| Proteinuria | 3 | 2007 | 594 | 0.370 |
Why?
|
| Hypolipidemic Agents | 1 | 2015 | 626 | 0.370 |
Why?
|
| Erythropoietin | 3 | 2015 | 720 | 0.370 |
Why?
|
| Hospitals, Special | 1 | 2011 | 90 | 0.370 |
Why?
|
| Humans | 144 | 2024 | 760613 | 0.370 |
Why?
|
| Mass Screening | 3 | 2016 | 5422 | 0.360 |
Why?
|
| Oxygen | 1 | 2022 | 4193 | 0.350 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1949 | 0.350 |
Why?
|
| Coronary Vasospasm | 1 | 2010 | 83 | 0.350 |
Why?
|
| Communicable Diseases | 1 | 2018 | 878 | 0.340 |
Why?
|
| Medicine | 1 | 2018 | 943 | 0.330 |
Why?
|
| Watchful Waiting | 1 | 2013 | 510 | 0.330 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 321 | 0.320 |
Why?
|
| Mitral Valve | 3 | 2013 | 1486 | 0.310 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 1155 | 0.310 |
Why?
|
| Heart Diseases | 4 | 2018 | 2809 | 0.300 |
Why?
|
| Ketoconazole | 5 | 1987 | 97 | 0.290 |
Why?
|
| Cholesterol | 2 | 2015 | 2924 | 0.280 |
Why?
|
| Sepsis | 2 | 2018 | 2592 | 0.280 |
Why?
|
| Glomerular Filtration Rate | 5 | 2019 | 2180 | 0.270 |
Why?
|
| Renin | 2 | 2016 | 635 | 0.270 |
Why?
|
| Air Pollution | 1 | 2020 | 2317 | 0.270 |
Why?
|
| Paromomycin | 4 | 1993 | 15 | 0.270 |
Why?
|
| Athletes | 1 | 2014 | 1125 | 0.270 |
Why?
|
| Smoking | 3 | 2018 | 9073 | 0.260 |
Why?
|
| Anemia | 3 | 2016 | 1511 | 0.260 |
Why?
|
| Hemodynamics | 6 | 2012 | 4173 | 0.260 |
Why?
|
| Terminal Care | 1 | 2018 | 1758 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1572 | 0.250 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3332 | 0.250 |
Why?
|
| Autonomic Nervous System Diseases | 5 | 1999 | 269 | 0.250 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2013 | 1419 | 0.250 |
Why?
|
| Schools | 1 | 2014 | 1480 | 0.240 |
Why?
|
| Calcium | 3 | 2024 | 5725 | 0.240 |
Why?
|
| Enalapril | 1 | 2016 | 313 | 0.230 |
Why?
|
| Heart Rate | 10 | 2017 | 4180 | 0.230 |
Why?
|
| Students | 1 | 2014 | 1730 | 0.220 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2660 | 0.220 |
Why?
|
| Stroke | 6 | 2019 | 9952 | 0.220 |
Why?
|
| Renal Artery Obstruction | 1 | 2004 | 224 | 0.210 |
Why?
|
| Hemorrhage | 1 | 2015 | 3599 | 0.210 |
Why?
|
| Glucagon-Like Peptides | 1 | 2024 | 159 | 0.200 |
Why?
|
| Diabetic Retinopathy | 4 | 2010 | 1268 | 0.200 |
Why?
|
| Cation Transport Proteins | 1 | 2024 | 325 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2018 | 3518 | 0.190 |
Why?
|
| Heart Failure, Systolic | 1 | 2013 | 136 | 0.190 |
Why?
|
| Male | 79 | 2019 | 359718 | 0.190 |
Why?
|
| Gram-Negative Bacteria | 1 | 2023 | 272 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3839 | 0.180 |
Why?
|
| Diabetic Neuropathies | 4 | 1999 | 406 | 0.180 |
Why?
|
| Coronary Disease | 6 | 2004 | 5991 | 0.180 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 531 | 0.180 |
Why?
|
| Cardiovascular System | 1 | 2007 | 850 | 0.170 |
Why?
|
| Neoplasms | 3 | 2018 | 22075 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1523 | 0.160 |
Why?
|
| Coronary Vessels | 2 | 2010 | 3112 | 0.160 |
Why?
|
| Female | 73 | 2019 | 391246 | 0.160 |
Why?
|
| Infusions, Intravenous | 5 | 2010 | 2235 | 0.160 |
Why?
|
| Aged | 36 | 2019 | 169143 | 0.160 |
Why?
|
| Benzethonium | 3 | 1987 | 6 | 0.160 |
Why?
|
| Sulfonylurea Compounds | 1 | 2020 | 221 | 0.160 |
Why?
|
| Registries | 1 | 2015 | 8458 | 0.160 |
Why?
|
| Postoperative Complications | 3 | 2017 | 15679 | 0.150 |
Why?
|
| Chest Pain | 2 | 2010 | 1106 | 0.150 |
Why?
|
| Esophageal Diseases | 1 | 1999 | 168 | 0.150 |
Why?
|
| Middle Aged | 54 | 2019 | 220359 | 0.150 |
Why?
|
| Fertilization | 1 | 2018 | 197 | 0.150 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 1987 | 202 | 0.140 |
Why?
|
| Phosphorus | 1 | 2018 | 333 | 0.140 |
Why?
|
| Glucuronidase | 1 | 2018 | 202 | 0.140 |
Why?
|
| Blood Viscosity | 1 | 1997 | 124 | 0.140 |
Why?
|
| Drug Therapy, Combination | 7 | 2016 | 6498 | 0.140 |
Why?
|
| Insulin Infusion Systems | 2 | 2017 | 217 | 0.140 |
Why?
|
| Balneology | 1 | 1996 | 2 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2015 | 5209 | 0.130 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 2420 | 0.130 |
Why?
|
| Leishmania mexicana | 2 | 1993 | 33 | 0.130 |
Why?
|
| Fibrinolysis | 1 | 1997 | 332 | 0.130 |
Why?
|
| Psoriasis | 3 | 1996 | 940 | 0.130 |
Why?
|
| Drug Resistance, Microbial | 1 | 2018 | 856 | 0.120 |
Why?
|
| Disease Progression | 8 | 2010 | 13505 | 0.120 |
Why?
|
| Motion Therapy, Continuous Passive | 1 | 2014 | 11 | 0.120 |
Why?
|
| Acute Kidney Injury | 8 | 1982 | 1941 | 0.120 |
Why?
|
| Antitubercular Agents | 1 | 2023 | 1373 | 0.120 |
Why?
|
| Adult | 53 | 2019 | 220007 | 0.120 |
Why?
|
| Diabetes Complications | 4 | 2005 | 1341 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2017 | 1259 | 0.110 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 497 | 0.110 |
Why?
|
| Hematoma | 1 | 1999 | 769 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 978 | 0.110 |
Why?
|
| Patient Advocacy | 1 | 1995 | 358 | 0.110 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 1174 | 0.110 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1992 | 63 | 0.110 |
Why?
|
| Risk Factors | 11 | 2019 | 74333 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 7408 | 0.100 |
Why?
|
| Coronary Angiography | 7 | 2010 | 4563 | 0.100 |
Why?
|
| Cause of Death | 3 | 2019 | 3725 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 869 | 0.100 |
Why?
|
| Heart | 3 | 2022 | 4393 | 0.100 |
Why?
|
| Angina Pectoris, Variant | 2 | 2010 | 56 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 580 | 0.100 |
Why?
|
| Health Care Rationing | 1 | 1995 | 435 | 0.100 |
Why?
|
| North America | 1 | 2016 | 1284 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 2 | 2006 | 141 | 0.100 |
Why?
|
| Australia | 1 | 2016 | 1290 | 0.100 |
Why?
|
| Prognosis | 7 | 2019 | 29661 | 0.100 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 1797 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2024 | 2001 | 0.100 |
Why?
|
| Follow-Up Studies | 13 | 2016 | 39262 | 0.090 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 1993 | 136 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6544 | 0.090 |
Why?
|
| Erythromycin Ethylsuccinate | 1 | 1990 | 2 | 0.090 |
Why?
|
| Muscle Tonus | 1 | 2010 | 82 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2011 | 1131 | 0.090 |
Why?
|
| Ethics, Medical | 1 | 1995 | 783 | 0.090 |
Why?
|
| Leishmaniasis, Mucocutaneous | 1 | 1989 | 14 | 0.090 |
Why?
|
| Hospital Units | 1 | 2011 | 142 | 0.090 |
Why?
|
| Creatinine | 5 | 1998 | 1904 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2018 | 2255 | 0.090 |
Why?
|
| Risk | 6 | 2018 | 9632 | 0.090 |
Why?
|
| Rifampin | 4 | 1987 | 340 | 0.090 |
Why?
|
| Renal Replacement Therapy | 1 | 2012 | 281 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 1109 | 0.080 |
Why?
|
| Lupus Vulgaris | 1 | 1989 | 10 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 25941 | 0.080 |
Why?
|
| Self Care | 1 | 2014 | 793 | 0.080 |
Why?
|
| Europe | 1 | 2016 | 3441 | 0.080 |
Why?
|
| Pemphigus | 3 | 1991 | 116 | 0.080 |
Why?
|
| Double-Blind Method | 4 | 2016 | 12427 | 0.080 |
Why?
|
| Glucosides | 1 | 2013 | 533 | 0.080 |
Why?
|
| Uracil | 1 | 1990 | 207 | 0.080 |
Why?
|
| Periodicity | 1 | 2010 | 348 | 0.080 |
Why?
|
| Valsalva Maneuver | 3 | 1998 | 99 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2016 | 888 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2014 | 613 | 0.080 |
Why?
|
| Treatment Failure | 2 | 2016 | 2647 | 0.080 |
Why?
|
| Contrast Media | 6 | 1991 | 5305 | 0.080 |
Why?
|
| Heart Block | 1 | 1990 | 392 | 0.080 |
Why?
|
| Triazoles | 1 | 2013 | 904 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58980 | 0.070 |
Why?
|
| Vasoconstriction | 1 | 2010 | 593 | 0.070 |
Why?
|
| Certification | 1 | 2011 | 421 | 0.070 |
Why?
|
| Pyrazines | 1 | 2013 | 1199 | 0.070 |
Why?
|
| Electrocardiography, Ambulatory | 5 | 1999 | 578 | 0.070 |
Why?
|
| Thromboembolism | 2 | 2013 | 1016 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 4167 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2021 | 41337 | 0.070 |
Why?
|
| Dapsone | 1 | 1987 | 56 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2018 | 10185 | 0.070 |
Why?
|
| Chondroblastoma | 1 | 1987 | 48 | 0.070 |
Why?
|
| Angiography | 4 | 1982 | 1605 | 0.070 |
Why?
|
| Benzhydryl Compounds | 1 | 2013 | 941 | 0.070 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 1986 | 42 | 0.070 |
Why?
|
| Lithium | 2 | 1991 | 596 | 0.070 |
Why?
|
| Health Expenditures | 1 | 2019 | 2362 | 0.070 |
Why?
|
| Uremia | 4 | 1984 | 201 | 0.070 |
Why?
|
| Echocardiography | 4 | 1992 | 4981 | 0.070 |
Why?
|
| Low Back Pain | 1 | 2014 | 979 | 0.060 |
Why?
|
| Bacteria | 1 | 2017 | 2199 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5508 | 0.060 |
Why?
|
| Prospective Studies | 14 | 2014 | 54306 | 0.060 |
Why?
|
| Models, Biological | 1 | 2022 | 9468 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2018 | 3185 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2013 | 1521 | 0.060 |
Why?
|
| Kidney Function Tests | 2 | 2005 | 681 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2009 | 8556 | 0.060 |
Why?
|
| Skin Transplantation | 5 | 1983 | 1083 | 0.060 |
Why?
|
| Vitamin D | 1 | 2018 | 3291 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2012 | 3959 | 0.060 |
Why?
|
| Penicillins | 1 | 1987 | 407 | 0.060 |
Why?
|
| Miconazole | 1 | 1984 | 9 | 0.060 |
Why?
|
| Verapamil | 1 | 1984 | 242 | 0.060 |
Why?
|
| Animals | 8 | 2024 | 167960 | 0.060 |
Why?
|
| Elephantiasis | 1 | 1983 | 11 | 0.060 |
Why?
|
| Lymphogranuloma Venereum | 1 | 1983 | 14 | 0.060 |
Why?
|
| Obesity | 4 | 2016 | 12919 | 0.060 |
Why?
|
| Clotrimazole | 1 | 1984 | 76 | 0.060 |
Why?
|
| Peritoneal Dialysis | 2 | 1988 | 157 | 0.060 |
Why?
|
| Electrocardiography | 6 | 2006 | 6415 | 0.060 |
Why?
|
| Hypertension, Renovascular | 1 | 2004 | 117 | 0.060 |
Why?
|
| Administration, Topical | 5 | 1993 | 697 | 0.060 |
Why?
|
| Circadian Rhythm | 4 | 1999 | 2570 | 0.060 |
Why?
|
| Amphotericin B | 1 | 1984 | 142 | 0.060 |
Why?
|
| Sympathetic Nervous System | 2 | 2014 | 520 | 0.050 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1983 | 110 | 0.050 |
Why?
|
| United States | 3 | 2021 | 72448 | 0.050 |
Why?
|
| Hospitalization | 1 | 2013 | 10789 | 0.050 |
Why?
|
| Metolazone | 1 | 1982 | 3 | 0.050 |
Why?
|
| Israel | 2 | 2014 | 722 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 1984 | 174 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12159 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 1986 | 506 | 0.050 |
Why?
|
| Genital Diseases, Female | 1 | 1983 | 191 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 1984 | 292 | 0.050 |
Why?
|
| Belize | 2 | 1993 | 15 | 0.050 |
Why?
|
| Polyarteritis Nodosa | 1 | 1982 | 70 | 0.050 |
Why?
|
| Diuretics | 2 | 1982 | 613 | 0.050 |
Why?
|
| Graft Survival | 1 | 1992 | 3795 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14494 | 0.050 |
Why?
|
| Hemostasis | 2 | 2005 | 468 | 0.050 |
Why?
|
| Calcinosis | 1 | 1990 | 1476 | 0.050 |
Why?
|
| Stroke Volume | 3 | 2016 | 5523 | 0.050 |
Why?
|
| Factor VII | 1 | 2001 | 139 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11902 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 1817 | 0.040 |
Why?
|
| Aortic Valve | 1 | 1990 | 1996 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 1860 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 1983 | 367 | 0.040 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2004 | 252 | 0.040 |
Why?
|
| Amyloid | 1 | 1984 | 842 | 0.040 |
Why?
|
| Phentermine | 1 | 1998 | 31 | 0.040 |
Why?
|
| Transplantation, Homologous | 5 | 1995 | 4815 | 0.040 |
Why?
|
| Fenfluramine | 1 | 1998 | 58 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 29957 | 0.040 |
Why?
|
| Hand | 2 | 1983 | 903 | 0.040 |
Why?
|
| Appetite Depressants | 1 | 1998 | 108 | 0.040 |
Why?
|
| Imidazoles | 1 | 1984 | 1180 | 0.040 |
Why?
|
| Rheumatic Fever | 1 | 1977 | 75 | 0.040 |
Why?
|
| Drainage | 1 | 1983 | 1161 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2010 | 5961 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 1999 | 366 | 0.040 |
Why?
|
| Amyloidosis | 1 | 1984 | 817 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5418 | 0.040 |
Why?
|
| Lymphedema | 1 | 1983 | 524 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2018 | 64981 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2005 | 8525 | 0.030 |
Why?
|
| Skin Neoplasms | 3 | 1987 | 5799 | 0.030 |
Why?
|
| Heart Valve Diseases | 2 | 1990 | 1047 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2013 | 760 | 0.030 |
Why?
|
| Oceans and Seas | 1 | 1996 | 47 | 0.030 |
Why?
|
| Jordan | 1 | 1996 | 73 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 1981 | 355 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2011 | 4360 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80345 | 0.030 |
Why?
|
| Mitral Valve Stenosis | 1 | 1977 | 348 | 0.030 |
Why?
|
| Adolescent | 8 | 2018 | 87809 | 0.030 |
Why?
|
| Leptin | 2 | 2014 | 1590 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2016 | 9288 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2009 | 22052 | 0.030 |
Why?
|
| Survival Rate | 3 | 1995 | 12810 | 0.030 |
Why?
|
| Posture | 2 | 1998 | 953 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 1987 | 2531 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1998 | 584 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2014 | 253 | 0.030 |
Why?
|
| Agglutination Tests | 1 | 1993 | 41 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 1982 | 916 | 0.030 |
Why?
|
| Isoniazid | 2 | 1987 | 283 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11890 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1995 | 777 | 0.030 |
Why?
|
| HLA-A Antigens | 1 | 1992 | 225 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 2128 | 0.020 |
Why?
|
| Resistin | 1 | 2012 | 172 | 0.020 |
Why?
|
| Organogold Compounds | 1 | 1991 | 5 | 0.020 |
Why?
|
| Albuminuria | 1 | 2015 | 659 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1977 | 1274 | 0.020 |
Why?
|
| Triglycerides | 2 | 2015 | 2476 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 1992 | 331 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 10546 | 0.020 |
Why?
|
| Heart Ventricles | 3 | 2004 | 3812 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 1993 | 316 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1992 | 630 | 0.020 |
Why?
|
| Leishmania braziliensis | 1 | 1989 | 16 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1992 | 532 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 1677 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1993 | 6216 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1992 | 838 | 0.020 |
Why?
|
| Aldosterone | 1 | 2014 | 868 | 0.020 |
Why?
|
| Ventricular Function, Left | 2 | 1992 | 3880 | 0.020 |
Why?
|
| Ointments | 2 | 1985 | 58 | 0.020 |
Why?
|
| Sulfates | 1 | 1990 | 379 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 1992 | 546 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2852 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 3322 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1992 | 1516 | 0.020 |
Why?
|
| Mycobacterium bovis | 1 | 1989 | 147 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12531 | 0.020 |
Why?
|
| Podocytes | 1 | 2012 | 402 | 0.020 |
Why?
|
| Diatrizoate | 2 | 1978 | 81 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6238 | 0.020 |
Why?
|
| Alopecia Areata | 1 | 1990 | 127 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1987 | 51 | 0.020 |
Why?
|
| Home Care Services | 1 | 2014 | 654 | 0.020 |
Why?
|
| Ampicillin | 1 | 1987 | 141 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 1995 | 1399 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1993 | 1347 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2916 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1998 | 2025 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1990 | 663 | 0.020 |
Why?
|
| Arthritis, Psoriatic | 1 | 1990 | 219 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1983 | 4024 | 0.020 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1987 | 74 | 0.020 |
Why?
|
| Urography | 2 | 1979 | 312 | 0.020 |
Why?
|
| Amoxicillin | 1 | 1987 | 180 | 0.020 |
Why?
|
| Adiponectin | 1 | 2012 | 1114 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3520 | 0.020 |
Why?
|
| Cocaine | 1 | 1991 | 961 | 0.020 |
Why?
|
| Skin | 3 | 1991 | 4466 | 0.020 |
Why?
|
| Zinc | 1 | 1990 | 689 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 1986 | 94 | 0.020 |
Why?
|
| Cell Division | 1 | 1993 | 4463 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 907 | 0.020 |
Why?
|
| Cisplatin | 1 | 1991 | 1643 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1983 | 9278 | 0.010 |
Why?
|
| Phenytoin | 1 | 1985 | 188 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2014 | 3527 | 0.010 |
Why?
|
| Clitoris | 1 | 1983 | 35 | 0.010 |
Why?
|
| Mast Cells | 1 | 1991 | 1390 | 0.010 |
Why?
|
| Vulvar Diseases | 1 | 1983 | 62 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1992 | 2255 | 0.010 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1985 | 247 | 0.010 |
Why?
|
| Heart Septum | 1 | 2004 | 303 | 0.010 |
Why?
|
| Ear, External | 1 | 1983 | 164 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10826 | 0.010 |
Why?
|
| Cholecystitis | 1 | 1983 | 181 | 0.010 |
Why?
|
| Hyperglycemia | 2 | 2000 | 1380 | 0.010 |
Why?
|
| Ulcer | 1 | 1983 | 204 | 0.010 |
Why?
|
| Time Factors | 5 | 2004 | 40139 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3448 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1385 | 0.010 |
Why?
|
| Lipids | 1 | 1993 | 3336 | 0.010 |
Why?
|
| Papillon-Lefevre Disease | 1 | 1981 | 4 | 0.010 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 1981 | 17 | 0.010 |
Why?
|
| Pruritus | 1 | 1985 | 377 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1999 | 1489 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 1991 | 1374 | 0.010 |
Why?
|
| Hypotension, Orthostatic | 1 | 1984 | 256 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 1983 | 406 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1991 | 2282 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1984 | 452 | 0.010 |
Why?
|
| Groin | 1 | 1980 | 106 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 901 | 0.010 |
Why?
|
| Mice | 4 | 1993 | 81209 | 0.010 |
Why?
|
| Edema | 1 | 1984 | 770 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1982 | 409 | 0.010 |
Why?
|
| Blood Platelet Disorders | 1 | 2000 | 61 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1978 | 153 | 0.010 |
Why?
|
| Transplantation, Autologous | 2 | 1981 | 2120 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2000 | 429 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1869 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1978 | 79 | 0.010 |
Why?
|
| Ergonovine | 1 | 1977 | 14 | 0.010 |
Why?
|
| Prolapse | 1 | 1977 | 63 | 0.010 |
Why?
|
| Leg Injuries | 1 | 1979 | 178 | 0.010 |
Why?
|
| Iothalamate Meglumine | 1 | 1977 | 9 | 0.010 |
Why?
|
| Nose Neoplasms | 1 | 1979 | 249 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24102 | 0.010 |
Why?
|
| Myxoma | 1 | 1977 | 114 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1985 | 1380 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1984 | 1501 | 0.010 |
Why?
|
| Iodine | 1 | 1979 | 286 | 0.010 |
Why?
|
| Cadaver | 1 | 1980 | 1345 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15840 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 805 | 0.010 |
Why?
|
| Epinephrine | 1 | 2000 | 791 | 0.010 |
Why?
|
| Nose | 1 | 1979 | 519 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 673 | 0.010 |
Why?
|
| Sodium | 1 | 1981 | 1594 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20509 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1984 | 1311 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7850 | 0.010 |
Why?
|
| Recurrence | 2 | 1985 | 8483 | 0.010 |
Why?
|
| Microcirculation | 1 | 2000 | 1278 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1991 | 4371 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1977 | 360 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3106 | 0.010 |
Why?
|
| Retina | 1 | 1984 | 2635 | 0.010 |
Why?
|
| Reoperation | 1 | 1983 | 4289 | 0.010 |
Why?
|
| Protein Binding | 1 | 1984 | 9335 | 0.010 |
Why?
|
| Collagen | 1 | 2000 | 2636 | 0.010 |
Why?
|
| Child | 4 | 1987 | 79799 | 0.010 |
Why?
|
| Zinc Sulfate | 1 | 1990 | 18 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 1990 | 97 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1991 | 700 | 0.010 |
Why?
|
| Family | 1 | 1980 | 3189 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23374 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1984 | 5078 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1979 | 1951 | 0.000 |
Why?
|
| Cell Count | 1 | 1991 | 1835 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1993 | 3465 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15286 | 0.000 |
Why?
|
| Leishmania tropica | 1 | 1985 | 8 | 0.000 |
Why?
|
| Inflammation | 1 | 2005 | 10755 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1991 | 720 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1990 | 2381 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1990 | 1368 | 0.000 |
Why?
|
| Nausea | 1 | 1987 | 678 | 0.000 |
Why?
|
| Vomiting | 1 | 1987 | 650 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1991 | 1403 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1985 | 42056 | 0.000 |
Why?
|
| Pedigree | 1 | 1990 | 4578 | 0.000 |
Why?
|
| Age Factors | 1 | 1978 | 18413 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 1784 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21391 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 20080 | 0.000 |
Why?
|
| Methods | 1 | 1979 | 1074 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1988 | 2782 | 0.000 |
Why?
|
| Neutrophils | 1 | 1990 | 3767 | 0.000 |
Why?
|
| Fracture Fixation | 1 | 1979 | 365 | 0.000 |
Why?
|
| Cardiomegaly | 1 | 1979 | 593 | 0.000 |
Why?
|
| Coronary Care Units | 1 | 1977 | 235 | 0.000 |
Why?
|
| Microsurgery | 1 | 1979 | 796 | 0.000 |
Why?
|
| Acute Disease | 1 | 1982 | 7268 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 8055 | 0.000 |
Why?
|